目的探讨原发性腹膜恶性肿瘤的临床治疗方案及预后相关因素。
Objective To investigate the clinical management strategies and prognostic factors of primary peritoneal neoplasms.
目的比较原发性腹膜恶性肿瘤采用不同化疗方案治疗对患者生存时间的影响。
Objective to explore and compare the effects of different chemotherapy regimens on the survival of patients with primary peritoneal neoplasms.
腹膜后恶性肿瘤切除术后，5年生存率为14．5％。
The 5-year survival rate for malignant retroperitoneal tumors is 14.5%.
恶性肿瘤住院病人疾病构成排在前3位的主要是消化器官和腹膜肿瘤、淋巴和造血组织肿瘤以及呼吸和胸腔内器官肿瘤。
The top 3 diseases of inpatients with malignant tumor were digestive and peritoneal tumor, lymph and haematogenous tissue tumor, respiratory and intrathoracal tumor.
结论：血液透析患者恶性肿瘤发病率明显高于腹膜透析患者。
Conclusion: The incidence of malignant tumors in hemodialysis patients is higher than that in continuance ambulatory peritoneal dialysis patients.
观察希罗达同步三维适形放疗治疗恶性肿瘤腹膜后淋巴结转移的近期疗效及毒副反应。
The objoctive of this study was to observe the efficacy and side effect of concurrent Xeloda and three-dimensional conformal radiotherapy(3DCRT)for retroperitoneal lymph node metastases.
本文报告了17例经二维及双功能多普勒超声诊断的腹膜后肿物，其中良性肿物3例(17.6%)，恶性肿瘤13例(76.5%)，有恶性倾向的肿瘤1例。
This article reports 17 cases with retroperitoneal masses diagnosed by 2-d imaging and duplex Doppler, including 3 benign masses (17.6%), 13 malignant tumor, (76.5%) and one malignant potential.
恶性肿瘤常伴腹水，盆腔或腹膜后淋巴结肿大，大网膜增厚呈饼状，腹腔种植转移和肝脏转移。
Malignant carcinomas usually presented with ascites, pelvic and post-peritoneum enlarged lymph nodes, greater omentum like biscuits, peritoneum implanting and liver metastases.
结论原发性腹膜后恶性肿瘤术前灌注是安全、有效的治疗方法，有助于外科手术治疗。
Conclusion Preoperative transcatheter arterial infusion is a safe, effective therapy for the treatment of PRMT, it is helpful to the surgery.
结论原发性腹膜后恶性肿瘤术前灌注是安全、有效的治疗方法，有助于外科手术治疗。
Conclusion Preoperative transcatheter arterial infusion is a safe, effective therapy for the treatment of PRMT, it is helpful to the surgery.
应用推荐